BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37154419)

  • 1. Sclerostin deficiency effectively promotes bone morphogenetic protein-2-induced ectopic bone formation.
    Nakamura K; Koide M; Kobayashi Y; Yamashita T; Matsushita M; Yasuda H; Ishihara Y; Yoshinari N; Udagawa N
    J Periodontal Res; 2023 Aug; 58(4):769-779. PubMed ID: 37154419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium.
    Ryan ZC; Ketha H; McNulty MS; McGee-Lawrence M; Craig TA; Grande JP; Westendorf JJ; Singh RJ; Kumar R
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6199-204. PubMed ID: 23530237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the major contribution of remodeling-based bone formation in sclerostin-deficient mice.
    Koide M; Yamashita T; Nakamura K; Yasuda H; Udagawa N; Kobayashi Y
    Bone; 2022 Jul; 160():116401. PubMed ID: 35381389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Long-Term Sclerostin Deficiency on Trabecular Bone Mass and Adaption to Limb Loading Differ in Male and Female Mice.
    Albiol L; Büttner A; Pflanz D; Mikolajewicz N; Birkhold AI; Kramer I; Kneissel M; Duda GN; Checa S; Willie BM
    Calcif Tissue Int; 2020 Apr; 106(4):415-430. PubMed ID: 31873756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury.
    Qin W; Zhao W; Li X; Peng Y; Harlow LM; Li J; Qin Y; Pan J; Wu Y; Ran L; Ke HZ; Cardozo CP; Bauman WA
    Osteoporos Int; 2016 Dec; 27(12):3627-3636. PubMed ID: 27436301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of mechanosensitive sclerostin may accelerate cranial bone growth and regeneration.
    Kang KS; Lastfogel J; Ackerman LL; Jea A; Robling AG; Tholpady SS
    J Neurosurg; 2018 Oct; 129(4):1085-1091. PubMed ID: 29125417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.
    Tu X; Rhee Y; Condon KW; Bivi N; Allen MR; Dwyer D; Stolina M; Turner CH; Robling AG; Plotkin LI; Bellido T
    Bone; 2012 Jan; 50(1):209-17. PubMed ID: 22075208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development.
    Yee CS; Manilay JO; Chang JC; Hum NR; Murugesh DK; Bajwa J; Mendez ME; Economides AE; Horan DJ; Robling AG; Loots GG
    J Bone Miner Res; 2018 Oct; 33(10):1748-1759. PubMed ID: 29750826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.
    Li X; Ominsky MS; Niu QT; Sun N; Daugherty B; D'Agostin D; Kurahara C; Gao Y; Cao J; Gong J; Asuncion F; Barrero M; Warmington K; Dwyer D; Stolina M; Morony S; Sarosi I; Kostenuik PJ; Lacey DL; Simonet WS; Ke HZ; Paszty C
    J Bone Miner Res; 2008 Jun; 23(6):860-9. PubMed ID: 18269310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.
    Kamiya N; Ye L; Kobayashi T; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
    Development; 2008 Nov; 135(22):3801-11. PubMed ID: 18927151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
    Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
    Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.
    Choi HY; Dieckmann M; Herz J; Niemeier A
    PLoS One; 2009 Nov; 4(11):e7930. PubMed ID: 19936252
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Mosey H; Núñez JA; Goring A; Clarkin CE; Staines KA; Lee PD; Pitsillides AA; Javaheri B
    Front Mater; 2017 Sep; 4():27. PubMed ID: 29349060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical bone adaptation to a moderate level of mechanical loading in male Sost deficient mice.
    Yang H; Büttner A; Albiol L; Julien C; Thiele T; Figge C; Kramer I; Kneissel M; Duda GN; Checa S; Willie BM
    Sci Rep; 2020 Dec; 10(1):22299. PubMed ID: 33339872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis.
    Jiao Z; Chai H; Wang S; Sun C; Huang Q; Xu W
    J Mol Med (Berl); 2023 May; 101(5):607-620. PubMed ID: 37121919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1.
    Kamiya N; Kaartinen VM; Mishina Y
    Biochem Biophys Res Commun; 2011 Oct; 414(2):326-30. PubMed ID: 21945937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.
    Robling AG; Niziolek PJ; Baldridge LA; Condon KW; Allen MR; Alam I; Mantila SM; Gluhak-Heinrich J; Bellido TM; Harris SE; Turner CH
    J Biol Chem; 2008 Feb; 283(9):5866-75. PubMed ID: 18089564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of SOST gene promotes bone formation through the Wnt/β-catenin signalling pathway and compensates particle-induced osteolysis.
    Zhang ZH; Jia XY; Fang JY; Chai H; Huang Q; She C; Jia P; Geng C; Xu W
    J Cell Mol Med; 2020 Apr; 24(7):4233-4244. PubMed ID: 32134561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone Volume.
    Morse A; Cheng TL; Schindeler A; McDonald MM; Mohanty ST; Kneissel M; Kramer I; Little DG
    Calcif Tissue Int; 2018 Sep; 103(3):298-310. PubMed ID: 29845410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.